Verastem Oncology Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress August 12, 2019
Bicycle Therapeutics Reports Second Quarter 2019 Financial Results and Provides Clinical Update August 12, 2019
TScan Therapeutics Formed to Overcome Challenges of Current Immunotherapies with Novel TCR Discovery Platform and $48 Million in Funding July 24, 2019
Axial Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of AB-2004 for Treatment of Gastrointestinal Dysfunction and Associated Behavioral Symptoms of Autism Spectrum Disorder July 16, 2019
